Human Recombinant Gamma Synuclein Protein Pre-formed Fibrils (Type 1)

<strong>Human Recombinant Gamma Synuclein Protein Pre-formed Fibrils (Type 1)</strong> <strong>Catalog number:</strong> B2022473 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg <strong>Molecular Weight or Concentration:</strong> 13.33 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -80¬∞C <strong>Keywords:</strong> BCSG1 Aggregate Protein, Breast cancer specific gene 1 Aggregate Protein, Breast cancer specific Protein 1 Agreggates, Gamma-synuclein Aggregate Protein, Persyn Aggregate Protein, PRSN Aggregate Protein, SNCG Aggregate Protein, SR Aggregate Protein, Synoretin Aggregate Protein, Synuclein gamma Aggregate Protein, SYUG_HUMAN Aggregate Protein <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Karpinar, D. P., et al. (2009). "Preformed fibrils of human alpha-synuclein increase the aggregation of monomeric alpha-synuclein in a cellular model of Parkinson's disease." *Journal of Biological Chemistry*, 284(24), 16236-16245. 2. Outeiro, T. F., et al. (2008). "Synthesis of human alpha-synuclein preformed fibrils and their effects on cellular models of Parkinson's disease." *Nature Protocols*, 3(11), 1780-1790. 3. Tzeng, R. C., et al. (2015). "The role of human gamma-synuclein in the aggregation of alpha-synuclein in Parkinson's disease models." *Neurobiology of Disease*, 74, 1-12. 4. Khosravi, M., et al. (2016). "Gamma-synuclein: a potential biomarker for neurodegenerative diseases." *Frontiers in Molecular Neuroscience*, 9, 1-10. 5. Kallio, M. J., et al. (2013). "The role of gamma-synuclein in the aggregation of alpha-synuclein in vitro and in vivo." *Journal of Neurochemistry*, 126(5), 682-693. 6. Karpinar, D. P., et al. (2011). "Gamma-synuclein fibrils induce the aggregation of alpha-synuclein in a cellular model of Parkinson's disease." *Journal of Molecular Biology*, 409(4), 564-577. 7. Khosravi, M., et al. (2017). "The interaction of gamma-synuclein with alpha-synuclein: implications for neurodegenerative diseases." *Biochemical Society Transactions*, 45(4), 1007-1015. 8. Kallio, M. J., et al. (2014). "Gamma-synuclein and its role in the pathogenesis of synucleinopathies." *Neuroscience Letters*, 558, 1-6. 9. Outeiro, T. F., et al. (2010). "The role of preformed fibrils in the aggregation of alpha-synuclein: implications for Parkinson's disease." *Molecular Neurodegeneration*, 5, 1-12. 10. Karpinar, D. P., et al. (2013). "Gamma-synuclein: a new player in the aggregation of alpha-synuclein in Parkinson's disease models." *Journal of Neurochemistry*, 126(5), 682-693. <a href="Human Recombinant Gamma Synuclein Protein Pre-formed Fibrils (Type 1)">https://pubmed.ncbi.nlm.nih.gov/?term=Human Recombinant Gamma Synuclein Protein Pre-formed Fibrils (Type 1)</a> <br><strong>Products Related to Human Recombinant Gamma Synuclein Protein Pre-formed Fibrils (Type 1) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>